Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jeremy Quintana, Ph.D.

Concepts (65)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Jeremy Quintana's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Jeremy Quintana has written about over time.
Adenine, 1 publications between 2016 and 2016, average publication date July 2016. Adjuvants, Immunologic, 1 publications between 2016 and 2016, average publication date July 2016. Toll-Like Receptor 7, 1 publications between 2016 and 2016, average publication date July 2016. Islets of Langerhans, 1 publications between 2017 and 2017, average publication date December 2017. Islets of Langerhans Transplantation, 1 publications between 2017 and 2017, average publication date December 2017. Toll-Like Receptor 4, 1 publications between 2017 and 2017, average publication date December 2017. Cell Line, Tumor, 4 publications between 2017 and 2024, average publication date August 2021. Interferon-gamma, 1 publications between 2021 and 2021, average publication date November 2021. Interleukin-12, 1 publications between 2021 and 2021, average publication date November 2021. Antibodies, Viral, 1 publications between 2022 and 2022, average publication date January 2022. Biosensing Techniques, 1 publications between 2022 and 2022, average publication date January 2022. Polymers, 1 publications between 2022 and 2022, average publication date January 2022. Pyrroles, 1 publications between 2022 and 2022, average publication date January 2022. Albumins, 2 publications between 2022 and 2022, average publication date May 2022. Doxorubicin, 1 publications between 2022 and 2022, average publication date July 2022. Immunoconjugates, 1 publications between 2022 and 2022, average publication date July 2022. Pharmaceutical Preparations, 1 publications between 2022 and 2022, average publication date July 2022. Antineoplastic Agents, 2 publications between 2022 and 2024, average publication date May 2023. Nanoparticles, 1 publications between 2024 and 2024, average publication date March 2024.

To see the data from this visualization as text, click here.
Quintana's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (65)
Explore
_
Co-Authors (13)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.